328 related articles for article (PubMed ID: 5605712)
1. [Effects of strophanthin on cardiovascular function and on tolerance of exercise in patients with angina pectoris treated with beta-adrenergic blocking].
Volta G; Pavarani A; Barbaresi F; Starcich R
G Clin Med; 1967 Oct; 48(10):1043-53. PubMed ID: 5605712
[No Abstract] [Full Text] [Related]
2. [The effect of nitroglycerin and of a new beta-blocking agent (metroprlolo) on exercise tolerance in ischemic patients].
Mosti GB; Tomei G; Giusti C; Galetta F; Rossi M; Santoro G
Boll Soc Ital Cardiol; 1978; 23(3):589-96. PubMed ID: 111693
[No Abstract] [Full Text] [Related]
3. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
Arstila M; Iisalo E; Kallio V
Ann Clin Res; 1969 May; 1(1):13-21. PubMed ID: 4390794
[No Abstract] [Full Text] [Related]
4. Human cardiovascular effects of alprenolol, a beta-adrenergic blocker: hemodynamic, antiarrhythmic, and antianginal.
Wasserman AJ; Proctor JD; Allen FJ; Kemp VE
J Clin Pharmacol J New Drugs; 1970; 10(1):37-49. PubMed ID: 4391785
[No Abstract] [Full Text] [Related]
5. [Study of the combined effect of alpha-blocking and beta-blocking drugs on tolerance to exertion in patients with acute coronary insufficiency].
Pavarani A; Volta G; Barbaresi F; Starcich R
Folia Cardiol; 1969; 28(1):37-41. PubMed ID: 4391632
[No Abstract] [Full Text] [Related]
6. [Positive and negative effects of beta-adrenergic blocking in angina pectoris. (Indications on the contemporary use of nitroglycerin and aminophylline)].
Starcich R; Barbaresi F; Volta G; Pavarani A
Minerva Cardioangiol; 1967 Dec; 15(12):835-43. PubMed ID: 4975623
[No Abstract] [Full Text] [Related]
7. Effects of alprenolol on central hemodynamics and exercise tolerance in patients with angina pectoris.
Jonsson B; Olsson AG; Orö L
Cardiology; 1973; 58(3):152-61. PubMed ID: 4149331
[No Abstract] [Full Text] [Related]
8. [Changes in intracardiac hemodynamics and the tolerance for physical loading as affected by Nitrong in persons suffering from ischemic heart disease].
Gasilin VS; Shevchenko OP; Maksumov EIu; Lupanov VP
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(1):59-64. PubMed ID: 6789850
[No Abstract] [Full Text] [Related]
9. [Paradoxal reaction to beta-adrenergic blocking therapy of coronary angina].
Dal Palù C; Gasparotto G; Stritoni P
Boll Soc Ital Cardiol; 1967; 12(2):104-8. PubMed ID: 5606862
[No Abstract] [Full Text] [Related]
10. Cardio-selective beta-adrenergic inhibition by practolol in angina pectoris.
Frick MH; Katila M
Fortn Rev Chic Dent Soc; 1970 Sep; 60(5):96-101. PubMed ID: 4393719
[No Abstract] [Full Text] [Related]
11. [Effect of beta-sympathicolysis on the working capacity of patients with coronary disease].
Heck KJ; Haas W; Lang E
Med Klin; 1972 Mar; 67(9):291-7. PubMed ID: 4558187
[No Abstract] [Full Text] [Related]
12. [Effect of a one-time dose of prolonged-action beta-adrenoblockaders and nitrates on the tolerance of physical loads in ischemic heart disease].
Ermilov LP; Kuleshova EV; Treshkur TV; Andreeva IV
Klin Med (Mosk); 1980 Apr; 58(4):77-81. PubMed ID: 6103973
[No Abstract] [Full Text] [Related]
13. [Anti-anginal activity of a beta-adrenergic blocking agent, butydrine, alone and in association with pentaerythritol tetranitrate, in the aged].
Gatti A; Scotti G
Clin Ter; 1967 May; 41(4):363-74. PubMed ID: 5614306
[No Abstract] [Full Text] [Related]
14. [Clinical experimentation with a combination of a beta-blocking agent and a nitro derivative in the prevention of anginous crises and in the basic treatment of coronary insufficiency].
Borroni G
Clin Ter; 1970 May; 53(3):247-58. PubMed ID: 4393972
[No Abstract] [Full Text] [Related]
15. [On the effect of the acute administration of strophanthin on tolerance to exertion in chronic coronary disease].
Raffo M; Biddau C; Lixi M; Bina M; Cherchi A
Boll Soc Ital Cardiol; 1966; 11(4):1560-7. PubMed ID: 5992070
[No Abstract] [Full Text] [Related]
16. The effect of a new beta blocking drug (butidrine) on some biohumoral indices, liver and kidney function and exercise tolerance.
Barbi G; Tallone B
Panminerva Med; 1969; 11(7):372-7. PubMed ID: 4390702
[No Abstract] [Full Text] [Related]
17. [Effect of isoptin on intrahepatic and central hemodynamics in ischemic heart disease].
Komissarov VA
Klin Med (Mosk); 1987 Sep; 65(9):64-7. PubMed ID: 3695314
[No Abstract] [Full Text] [Related]
18. [Problems in selecting the optimal propranolol dose in treating patients with angina pectoris of effort and the comparative effectiveness of inderal, anaprilin and obzidan].
Romakov AIu; Mazur NA
Ter Arkh; 1984; 56(9):41-6. PubMed ID: 6515546
[TBL] [Abstract][Full Text] [Related]
19. Effects of a cardio-selective beta-adrenergic blocker (I.C.I. 50172) at exercise in angina pectoris.
Areskog NH; Adolfsson L
Br Med J; 1969 Jun; 2(5657):601-3. PubMed ID: 5798470
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the effects of propranolol and practolol on the exercise tolerance in angina pectoris.
Coltart DJ; Hamer J
Br J Pharmacol; 1970 Sep; 40(1):147P-148P. PubMed ID: 4395080
[No Abstract] [Full Text] [Related]
[Next] [New Search]
